DURECT Corporation (DRRX): Price and Financial Metrics

DRRX POWR Grades

• Sentiment is the dimension where DRRX ranks best; there it ranks ahead of 78.23% of US stocks.
• DRRX's strongest trending metric is Growth; it's been moving up over the last 179 days.
• DRRX ranks lowest in Momentum; there it ranks in the 12th percentile.

DRRX Stock Summary

• With a one year PEG ratio of 0.17, Durect Corp is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than just 1.28% of US stocks.
• Over the past twelve months, DRRX has reported earnings growth of -2,161.45%, putting it ahead of merely 0.9% of US stocks in our set.
• As for revenue growth, note that DRRX's revenue has grown -53.58% over the past 12 months; that beats the revenue growth of only 2.93% of US companies in our set.
• Stocks with similar financial metrics, market capitalization, and price volatility to Durect Corp are BBI, ATNM, INFI, ZSAN, and SONN.
• DRRX's SEC filings can be seen here. And to visit Durect Corp's official web site, go to www.durect.com.

DRRX Valuation Summary

• DRRX's EV/EBIT ratio is -12.9; this is 144.03% lower than that of the median Healthcare stock.
• DRRX's price/sales ratio has moved down 10.8 over the prior 243 months.
• DRRX's EV/EBIT ratio has moved down 4.8 over the prior 243 months.

Below are key valuation metrics over time for DRRX.

DRRX Growth Metrics

The 4 year price growth rate now stands at 92.31%.
• Its 2 year cash and equivalents growth rate is now at -17.16%.
• Its year over year net cashflow from operations growth rate is now at -1037.98%.

Over the past 37 months, DRRX's revenue has gone down $4,587,000.

The table below shows DRRX's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-12-31	13.977	-37.311	-36.265
2021-09-30	5.489	-34.58	-24.897
2021-06-30	6.007	-35.905	-24.252
2021-03-31	29.548	-36.553	-0.768
2020-12-31	30.111	-38.704	-0.582
2020-09-30	41.987	-26.347	-9.173

DRRX's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• DRRX has a Quality Grade of C, ranking ahead of 38.99% of graded US stocks.
• DRRX's asset turnover comes in at 0.065 -- ranking 305th of 680 Pharmaceutical Products stocks.
• CCXI, LCI, and BHC are the stocks whose asset turnover ratios are most correlated with DRRX.

The table below shows DRRX's key quality metrics over time.